These results, together with a past report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 assist the notion of targeting ACKR3 as a unique technique to modulate the opioid process, which could open new therapeutic avenues for opioid-similar Problems. Name your selection: Identify need to https://johnm593hjo1.wikibriefing.com/user